Healthcare Finance News December 9, 2024
Susan Morse

In population health, a 10% weight loss makes a huge difference, say experts.

GLP-1 drugs such as Ozempic and Wegovy have completely changed not only how physicians manage weight loss but how healthcare views obesity.

Obesity has long come with the stigma of being weak. The way to lose weight, people have been told, is to “just eat less and move more,” said Dr. Craig Primack, obesity specialist and senior vice president of weight management at Hims and Hers, during “The Evolving Landscape of Innovations for More Equitable Obesity Care and Weight Loss Management,” webinar sponsored by HIMSS and the National Health IT Collaborative for the Underserved on Thursday. HIMSS is the parent company of Healthcare Finance News.

This...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Patient / Consumer, Pharma / Biotech, Trends
How has U.S. Spending on Health Care Changed Over Time?
Merck enters $2B licensing deal for weight loss drug
How Medicare Negotiated Drug Prices Compare to Other Countries
The Fed's Warnings On Inflation Are Bad News For Biotech Startups
AI Tech Firm SandboxAQ Adds $300M to Ramp Up Development of LQMs for Drug Discovery & More

Share This Article